![]() |
Biomea Fusion, Inc. (BMEA) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Biomea Fusion, Inc. (BMEA) Bundle
Verbessern Sie Ihre Anlagestrategien mit dem DCF -Taschenrechner von Biomea Fusion, Inc. (BMEA)! Verwenden Sie tatsächliche Finanzdaten aus Biomea -Fusion, passen Sie Wachstumsprojektionen und -kosten an und beobachten Sie sofort, wie sich diese Anpassungen auf den inneren Wert von Biomea Fusion, Inc. (BMEA) auswirken.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | .0 | -5.3 | -41.4 | -82.9 | -124.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | 1.2 | .1 | 1.0 | 1.3 | 1.5 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -1.2 | -5.5 | -42.4 | -84.2 | -126.1 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | .2 | 61.7 | 175.7 | 113.4 | 176.9 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | .3 | .7 | 1.3 | 6.8 | 6.9 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | .0 | -.1 | -3.2 | -1.0 | -3.4 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -1.2 | -5.5 | -42.0 | -82.3 | -126.1 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | .3 | -4.9 | -43.6 | -76.6 | -128.0 | -6.9 | .0 | .0 | .0 | .0 |
WACC, % | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 |
PV UFCF | ||||||||||
SUM PV UFCF | -6.5 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -7 | |||||||||
Net Debt | -167 | |||||||||
Equity Value | 160 | |||||||||
Diluted Shares Outstanding, MM | 34 | |||||||||
Equity Value Per Share | 4.69 |
What You Will Get
- Real BMEA Financial Data: Pre-filled with Biomea Fusion’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Biomea Fusion’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Model: Features detailed unlevered and levered DCF valuation frameworks tailored for Biomea Fusion, Inc. (BMEA).
- WACC Analysis Tool: Pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Inputs: Adjust growth projections, capital investments, and discount rates as needed.
- Integrated Financial Metrics: Evaluate profitability, leverage, and efficiency ratios specific to Biomea Fusion, Inc. (BMEA).
- Interactive Dashboard and Visuals: Graphical representations provide a summary of essential valuation indicators for straightforward analysis.
How It Works
- Download: Obtain the pre-built Excel file containing Biomea Fusion, Inc.'s (BMEA) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare results.
- Make Decisions: Leverage the valuation insights to inform your investment strategy.
Why Choose This Calculator for Biomea Fusion, Inc. (BMEA)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your financial analysis.
- Real-Time Valuation: Observe immediate updates to Biomea Fusion’s valuation as you modify inputs.
- Preloaded Data: Comes with Biomea Fusion’s current financial metrics for swift evaluations.
- Widely Endorsed: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Accurately assess Biomea Fusion’s fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Biomea Fusion (BMEA).
- Consultants: Easily customize the template for valuation reports tailored to clients interested in Biomea Fusion (BMEA).
- Entrepreneurs: Acquire knowledge about financial modeling techniques employed by leading biotech firms.
- Educators: Implement it as a teaching resource to illustrate various valuation methodologies.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Biomea Fusion, Inc. (BMEA) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Biomea Fusion, Inc. (BMEA).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.